Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Radiological and clinical outcomes of 3-level cervical disc arthroplasty.

Chang HK, Huang WC, Tu TH, Fay LY, Kuo CH, Chang CC, Wu CL, Lirng JF, Wu JC, Cheng H, Hsu SM.

J Neurosurg Spine. 2019 Nov 1;32(2):174-181. doi: 10.3171/2019.8.SPINE19545.

PMID:
31675702
2.

Image-guided study of inter-fraction and intra-fraction set-up variability and margins in reverse semi-decubitus breast radiotherapy.

Lee J, Liu SH, Lin JB, Wu MH, Wu CJ, Tai HC, Hsu SM, Chen YJ, Tai JC, Chen YJ.

Radiat Oncol. 2018 Dec 27;13(1):254. doi: 10.1186/s13014-018-1200-1.

3.

Construction of the REACHES climate database based on historical documents of China.

Wang PK, Lin KE, Liao YC, Liao HM, Lin YS, Hsu CT, Hsu SM, Wan CW, Lee SY, Fan IC, Tan PH, Ting TT.

Sci Data. 2018 Dec 18;5:180288. doi: 10.1038/sdata.2018.288.

4.

The Dosimetric Impact of Shifts in Patient Positioning during Boron Neutron Capture Therapy for Brain Tumors.

Lee JC, Chen YW, Chuang KS, Hsu FY, Chou FI, Hsu SM, Yen SH, Wu YH.

Biomed Res Int. 2018 Oct 1;2018:5826174. doi: 10.1155/2018/5826174. eCollection 2018.

5.

The Effect of Body Mass Index and Weight Change on Late Gastrointestinal Toxicity in Locally Advanced Cervical Cancer Treated With Intensity-modulated Radiotherapy.

Lee J, Chang CL, Lin JB, Wu MH, Sun FJ, Wu CJ, Tai HC, Hsu SM, Chen YJ.

Int J Gynecol Cancer. 2018 Sep;28(7):1377-1386. doi: 10.1097/IGC.0000000000001312.

PMID:
29994908
6.

Skeletal Muscle Loss Is an Imaging Biomarker of Outcome after Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer.

Lee J, Chang CL, Lin JB, Wu MH, Sun FJ, Jan YT, Hsu SM, Chen YJ.

Clin Cancer Res. 2018 Oct 15;24(20):5028-5036. doi: 10.1158/1078-0432.CCR-18-0788. Epub 2018 Jun 29.

7.

Calcium Phosphate Cement with Antimicrobial Properties and Radiopacity as an Endodontic Material.

Shieh TM, Hsu SM, Chang KC, Chen WC, Lin DJ.

Materials (Basel). 2017 Oct 31;10(11). pii: E1256. doi: 10.3390/ma10111256.

8.

Dosimetric comparison of different treatment modalities for stereotactic radiotherapy.

Hsu SM, Lai YC, Jeng CC, Tseng CY.

Radiat Oncol. 2017 Sep 16;12(1):155. doi: 10.1186/s13014-017-0890-0.

9.

Impact of radiation attenuation by a carbon fiber couch on patient dose verification.

Yu CY, Chou WT, Liao YJ, Lee JH, Liang JA, Hsu SM.

Sci Rep. 2017 Feb 27;7:43336. doi: 10.1038/srep43336.

10.

Development of delineation for the left anterior descending coronary artery region in left breast cancer radiotherapy: An optimized organ at risk.

Lee J, Hua KL, Hsu SM, Lin JB, Lee CH, Lu KW, Dai KY, Huang XN, Huang JZ, Wu MH, Chen YJ.

Radiother Oncol. 2017 Mar;122(3):423-430. doi: 10.1016/j.radonc.2016.12.029. Epub 2017 Jan 10.

PMID:
28087071
11.

Feasibility Study on Applying Radiophotoluminescent Glass Dosimeters for CyberKnife SRS Dose Verification.

Hsu SM, Hung CH, Liao YJ, Fu HM, Tsai JT, Huang YH, Huang DY.

PLoS One. 2017 Jan 3;12(1):e0169252. doi: 10.1371/journal.pone.0169252. eCollection 2017.

12.

A volume-equivalent spherical necrosis-tumor-normal liver model for estimating absorbed dose in yttrium-90 microsphere therapy.

Wu CH, Liao YJ, Lin TY, Chen YC, Sun SS, Liu YH, Hsu SM.

Med Phys. 2016 Nov;43(11):6082.

PMID:
27806615
13.
14.

Niemann-Pick Type C2 Protein Mediates Hepatic Stellate Cells Activation by Regulating Free Cholesterol Accumulation.

Twu YC, Lee TS, Lin YL, Hsu SM, Wang YH, Liao CY, Wang CK, Liang YC, Liao YJ.

Int J Mol Sci. 2016 Jul 13;17(7). pii: E1122. doi: 10.3390/ijms17071122.

15.

HDR Brachytherapy Dose Distribution is Influenced by the Metal Material of the Applicator.

Wu CH, Liao YJ, Shiau AC, Lin HY, Hsueh Liu YW, Hsu SM.

Sci Rep. 2015 Dec 11;5:17863. doi: 10.1038/srep17863.

16.

Niemann-Pick type C2 protein regulates liver cancer progression via modulating ERK1/2 pathway: Clinicopathological correlations and therapeutical implications.

Liao YJ, Fang CC, Yen CH, Hsu SM, Wang CK, Huang SF, Liang YC, Lin YY, Chu YT, Arthur Chen YM.

Int J Cancer. 2015 Sep 15;137(6):1341-51. doi: 10.1002/ijc.29507. Epub 2015 Mar 24.

17.

Influence of metal of the applicator on the dose distribution during brachytherapy.

Wu CH, Shiau AC, Liao YJ, Lin HY, Liu YW, Hsu SM.

PLoS One. 2014 Aug 18;9(8):e104831. doi: 10.1371/journal.pone.0104831. eCollection 2014.

18.

A study on the dose distributions in various materials from an Ir-192 HDR brachytherapy source.

Hsu SM, Wu CH, Lee JH, Hsieh YJ, Yu CY, Liao YJ, Kuo LC, Liang JA, Huang DY.

PLoS One. 2012;7(9):e44528. doi: 10.1371/journal.pone.0044528. Epub 2012 Sep 5.

19.

The clinical application of 4D 18F-FDG PET/CT on gross tumor volume delineation for radiotherapy planning in esophageal squamous cell cancer.

Wang YC, Hsieh TC, Yu CY, Yen KY, Chen SW, Yang SN, Chien CR, Hsu SM, Pan T, Kao CH, Liang JA.

J Radiat Res. 2012 Jul;53(4):594-600. doi: 10.1093/jrr/rrs009. Epub 2012 Jun 5.

20.

Air kerma standard and measurement comparison on source strength determination for high-dose rate 192Ir brachytherapy in Taiwan.

Lee JH, Su SH, Hsieh MT, Chen IJ, Liang JA, Hsu SM.

Radiat Prot Dosimetry. 2011 Jul;146(1-3):100-2. doi: 10.1093/rpd/ncr121. Epub 2011 Apr 16.

PMID:
21498859

Supplemental Content

Loading ...
Support Center